Oseltamivir Versus Paracetamol for Influenza-like Illness During the Influenza Season
Status:
Not yet recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Parallel group, investigator initiated, 1:1, open-label, non-inferiority randomized
controlled trial, aiming to show that paracetamol is non-inferior to oseltamivir among
patients with serious acute respiratory infection (SARI).